Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Ceftazidime-avibactam versus meropenem in nosocomial pneu... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial
0
Authors
Antoní Torres
10 more
Antoní Torres
•
Nanshan Zhong
8 more
•
Joseph Chow
Published
December 16, 2017
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Infectious Diseases
Topics
Biology
Microbiology
Medicine
Internal Medicine
Surgery
Show all topics
DOI
10.1016/s1473-3099(17)30747-8
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Infectious Diseases
Topics
Biology
Microbiology
Medicine
Internal Medicine
Surgery
Show all topics
DOI
10.1016/s1473-3099(17)30747-8
Other Formats
PDF